Fundamentals

Valuation

Metric	Q3	Q4	Δ in %
EV/EBITDA	-50.37	13.61	27.43
Graham Fair Price	13.25	3078.86	2718.53
PEG	-5.56	0.49	-0.52
Price/Book	-1.85	1.00	1.02
Price/Cash Flow	4.03	40.18	38.62
Prices/Earnings	-20.40	12.59	15.81
Price/Sales	-7.60	2.43	2.63
Price/FCF	4.03	40.18	38.62
Naive Interpretation	member

01 - Valuation · Somewhat Positive

Fundamentals

Profitability

Metric	Q3	Q4	Δ in %
Gross Profit Margin	-8.68	0.34	0.37
Operating Margin	24.41	0.08	0.06
ROA	23.20	0.02	0.01
ROE	0.02	0.02	23.30
ROIC	0.02	0.03	62.08
Naive Interpretation	member

02 - Profitability · Not Interpreted

Fundamentals

Financial Growth

Metric	Q3	Q4	Δ in %
Debt QOQ	-0.93	< 0.005	-11660.34
Dividends QOQ	0.00	0.00	0.00
EBIT QOQ	-0.30	0.35	14.84
EPS QOQ	-0.31	0.26	-15.71
FCF QOQ	0.03	-0.04	47.31
Revenue QOQ	-0.09	0.08	-3.33
Naive Interpretation	member

03 - Financial Growth · Balanced

Fundamentals

Leverage & Liquidity

Metric	Q3	Q4	Δ in %
Assets Turnover	n.A.	n.A.	n.A.
Days Inventory Outstanding (DIO)	42.13	34.44	-18.24
Days Sales Outstanding (DSO)	12.51	11.09	-11.35
Inventory Turnover	2.14	2.61	22.32
Debt/Capitalization	0.00	< 0.005	100.00
Quick Ratio	1.76	1.85	5.54
Naive Interpretation	member

04 - Leverage & Liquidity · Weak

Fundamentals

Per Share Metrics

Metric	Q3	Q4	Δ in %
Book Value	4516.68	4606.76	1.99
Cash	1610.79	1774.34	10.15
Capex	0.00	-27.40	-100.00
Free Cash Flow	119.11	114.62	-3.77
Revenue	1750.38	1896.47	8.35
Naive Interpretation	member

05 - Per Share Metrics · Positive

Fundamentals

Financial Health

Metric	Q3	Q4	Δ in %
Current Ratio	2.31	2.38	2.72
Debt/Assets	n.A.	n.A.	n.A.
Debt/Equity	n.A.	n.A.	n.A.
Net Debt/EBITDA	-13.07	-8.46	35.27
Naive Interpretation	Member

06 - Financial Health · Bad

Rating